New Delhi: The fate of nearly 2 lakh students across the county hangs in the balance with the Ministry of Human Resource Development (MHRD) announcing de-recognition of 44 deemed universities, which were found to be deficient on many grounds.Citing the reason that these universities are being run as "family fiefdoms" rather than "institutions of academic excellence", Solicitor General Gopal Subramanium made this submission to a bench of Justice Dalveer Bhandari and Justice Mukundkam Sharma, during the hearing of a 2006 lawsuit, questioning the misuse of the deemed university status by glut of educational shops.Out of the 44 universities listed for de-recognition, Tamil Nadu alone has 16, followed by Karnataka (6), Uttar Pradesh (4) and Maharashtra, Rajasthan and Haryana (3).The 44 deemed universities which have been listed for de-recognition include the following:
TAMIL NADUSt. Peter's Institute of Higher Education & ResearchNoorul Islam Centre for Higher EducationChettinad Academy of Research & EducationMeenakshi Academy of Higher Education & ResearchDr. MGR Educational & Research InstituteSaveetha Institute of Medical and Technical SciencesKalasalingam Academy of Research and EducationPeriyar Maniammai Institute of Science and TechnologyAcademy of Maritime Education and TrainingVel's Institute of Science, Tech & Advanced StudiesKarpagam Academy of Higher EducationVinayaka Mission's Research FoundationBharath Institute of Higher Education and ResearchPonnaiyah Ramajayam Institute of Science & TechnologyRajiv Gandhi National Institute of Youth DevelopmentVel Tech Rangarajan Dr. Sakunthala R&D Institute of Science & Technology
KARNATAKA
Sri Siddhartha Academy of Higher Education
Sri Devaraj Urs Academy of Higher Education & Research
Yenepoya University
BLDE University
Jain University
Christ University
UTTAR PRADESH
Shobhit Institute of Information Technology
Jaypee Institute of Information Technology
Santosh University
Nehru Gram Bharati University
MAHARASHTRA
DY Patil Medical College
Krishna Institute of Medical Sciences
Tilak Maharashtra Vidyapeeth
RAJASTHAN
Janardan Rai Nagar Rajasthan
VidyapeethIASE University (Sardarshahr)
Mody Institute of Technology and Science
HARYANA
Manav Rachna International University
Lingaya's University
Maharishi Markandeshwar University
UTTARAKHAND
Gurukula Kangri Vishwavidyalaya
Graphic Era University
OTHERS
Nava Nalanda Mahavihara (Bihar)
National Museum Institute (New Delhi)
Vignan's Foundation for Science, Tech & Research (Andhra Pradesh)
Sumandeep University(Gujarat)
Siksha 'O' Anusandhan University (Orissa)
Sri Balaji Vidyapeeth(Puducherry)
Monday, January 25, 2010
LIST OF APPROVED DRUGS DURING 2009 (upto 31-10-2009)
Sr.No.
Drug Name
Indication
Approval Date
1.
Zoledronic Acid Injection 5mg/100ml (Addl. Indication)
For the treatement of osteoporosis in post-menopausal women and in men who are at increased risk of fracture, including those with a recent low-trauma hip fracture.
07.01.09
2.
Misoprostol Tablet 600mcg
Addl. Strength
09.01.09
3.
Acebrophylline Syrup 10mg/ ml
For the treatement of adult patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma.
09.01.09
4.
Selamectin Tropical solution (for verterinary use.) 60mg/120mg per ml
(I) For the treatement and lasting prevention of flea infestations,treatment and control of flea allergy dermatitis, prevention of heartworm disease,treatement and prevention of ear mites in dogs and cats;
(II) For the treatement and prevention of sarcoptic mange, roundworms and for control of tick infestations in dogs.
09.01.09
5.
Methylcobalamin1500mcg + Calcium 200mg + Calcitriol 0.25mcg + Folic Acid1.5mg + Pyridoxine3mg Capsules
For the treatment of vitamin deficiency states in adults
14.01.09
6.
Metoprolol tartrate tablets 50 mg (Addl. Indication)
Adjunct to the treatement of Hyperthyroidism
14.01.09
7.
Cinacalet (as HCl) Tablet 30/60/90mg
For the treatment of secondary hyper parathyroidism in patients with chronic kidney diseases (CKD) on dialysis and for hypercalcemia in patients with parathyroid carcinoma
14.01.09
8.
Mycophenolate mofetil Capsules 250mg, Tablets 500mg, Oral suspension 200mg/ml (addl. Indication)
For the prophylaxis of acute organ rejection in patients recieving allogenic hepatic transplantation.
23.01.09
9.
Liquid Paraffin1.25ml + Milk of Magnesia 3.75ml + Sodium Picosulphate 3.33mg per 5ml
For symptomatic treatment of constipation in adults
29.01.09
10.
Ranolazine 1000mg ER Tabs (Additional Strength)
Same as approved
31.01.09
11.
Hyaluronic acid (cross linked) Pre-filled syringe 18mg/0.6ml and 24mg/0.8ml
For intradermal implantation and facial soft tissue augmentation
31.01.09
12.
Caspofungin acetate Injection (Addl. Indication)
For use in following: (I) Empirical therapy for presumed fungal infections in febrile neutropenic patients.
(II) Treatment of Candidemia and the following Candida infections: Intra-abdominal abscesses, Peritonitis and Pleural space infections.
(III) Treatment of Esophageal Candidiasis.
(IV) Treatment of invasive Aspergillosis in patients who are refractory to or intolerant of other therapies (i.e, amphotericin B, lipid formulations of amphotericin B, and/or itraconazole)
31.01.09
13.
Micafungin ( as sodium) Powder for solution for infusion 50mg / vial
For the treatment of patients with candidemia, acute disseminated candidiasis, candida peritonitis, abscess and esophageal candidiasis. For the prophylaxis of Candida infection in patients undergoing hematopoietic stem cell transplantation (HSCT)
31.01.09
14.
Loteprednol Etabonate Nasal spray 0.1% w/v
For prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis.
31.01.09
15.
Rasagiline (as mesylate ) Tablet 0.5mg/1mg
For the tratment of signs and symptoms of idiopathic Parkinson's disease as intial monotherapy and as an addition to levodopa.
31.01.09
16.
Nicotine Polacrilex Gum 2mg & 4mg (Addl. Indication)
To reduce the withdrawal symptoms, including nicotine craving, associated with quitting the smoking and quitting chewed tobacco and guthka containing tobacco.
03.02.09
17.
Closantel Injection100mg/ ml (for verterinary use.)
For the infestation of trematodes, nematodes, cestodes and arthropods of domestic animals, including milch and other food producing animals.
05.02.09
18.
Lornoxicam 4mg + Paracetamol 500mg film coated tablets
For the short term use in acute painful & inflammatory conditions in adults
05.02.09
19.
Cetrimide15% w/v + Chlorhexidine Gluconate 7.5% v/v + Isopropyl Alcohol 7.5% v/v Concentrate Solution
For cleansing of physically contaminated wounds and for pre-operative disinfection
09.02.09
20.
Ketoconazole 2% w/v + Prepared Coal Tar 2% w/v (I.P. 1966) Solution
For the treatment of dandruff
09.02.09
21.
Doripenem (as monohydrate) Injection 250mg/500mg
For the treatment of nosocomial pneumonia in adults.
16.02.09
22.
Halobetasol Scalp Approved 0.05% w/v
For the relief of inflammatory and puritic manifestation of corticosteroid respensive dermatosis
18.02.09
23.
Nicotine (as Polacrilex) Lozenges 2mg & 4mg
To reduce the withdrawal symptoms, including nicotine craving, associated with quitting the smoking and quitting chewed tobacco and guthka containing tobacco.
18.02.09
24.
Tranexamic Acid Tab SR 750mg
For the treatment of menorrhagia
20.02.09
25.
Betahistine Mesilate Tablet 6mg/12mg
For the treatment of dizziness and feeling of dizziness resulting from Meniere's disease, Meniere's syndrome and vertigo.
20.02.09
26.
Abatacept Injection 250mg/vial (Addl. Indication)
In moderately to severly active rheumatoid arithritis in adults and may be used as monotherapy or concomitantly with DMARD's other than TNF antagonists
20.02.09
27.
Anidulafungin Injection (Lyophilized powder) 50mg/100mg per vial
For the treatment of invasive candidiasis including candidemia and esophageal candidiasis in adult patients.
23.02.09
28.
Hydroquinone 2%+ Tretinoin 0.05% + Hydrocortisone1%Cream
For the treatment of patients with skin hyperpigmentation
23.02.09
29.
Doxyphylline 400 mg + Terbutaline 5mg tablets
For the treatment of asthma and chronic obstructive pulmonary disease in adult patients only
23.02.09
30.
Hydroquinone 20mg + Tretinoin 0.25mg + Fluocinolone Acetonide 0.1mg per gm Cream
For the treatment of melasma of face in adults
23.02.09
31.
Ketoconazole 2% + Zinc Pyrithone 1% Lotion
For the treatment of pityriasis and dandruff of the scalp
23.02.09
32.
Lamivudine 30mg + Zidovudine 60mg + Nevirapine 50mg Oral Suspension (Tablets for oral Suspension)
For the treatment of HIV patients
23.02.09
33.
Glibenclamide 5mg + Pioglitazone 15mg + Metformin500mg film coated tablets
As 3rd line treatment of type II diabetes mellitus when diet, exercise and the single agents and the second line therapy with two drugs do not result in adequate glycemic control
23.02.09
34.
Aceclofenac 100mg + Tizanidine 2mg film coated tablets
For the treatment of acute low back pain in adult patients only
23.02.09
35.
Octinoxate 7.5% + Avobenzone 3% + Oxybenzone 3% + Titanium dioxide 2% lotion
As sunscreen lotion for prevention of sunburn skin
23.02.09
36.
Cetrizine 5/10mg + Ambroxol 30mg per 5ml syrup
For the symptomatic relief of productive cough associated with allergic rhinitis, when both anti-histamine and mucolytic agents are desired
23.02.09
37.
Lidocaine Lozenges 200/300mg
For single agent anesthesia in upper gastro intestinal endoscopy.
26.02.09
38.
Calamine 8% + Liquid Paraffin10% lotion
As antipruritic and smoothening agent
26.02.09
39.
Nifedipine 0.3% + Lidocaine1.5% cream
For the treatment of anal fissures
26.02.09
40.
Quinapril 20mg + HCTZ 25mg film coated tablet
For the treatment of mild to moderate hypertension in adult patients (in whom combination therapy is appropriate) who have been stabilized on the individual components given in the same proportion
26.02.09
41.
Levodopa 100/100/250 + Carbidopa 10/25/25mg mouth dissolving tablet
For the symptomatic symptoms of idiopathic Parkinson's Disease
04.03.09
42.
Paliperidone ER Tablets 1.5mg
Addl. Strength
04.03.09
43.
Losartan 100mg+ HCTZ 25 mg tablet
Additional higher strength
16.03.09
44.
Darunavir(as ethanolate) Tablet 300mg
For the treatment of human immunodeficiency virus (HIV) infection in antiretroviral treatment experienced adult patients, such as those patients with HIV-1 strains resistant to more than one protease inhibitor when co-administered with 100mg ritonavir, and with other antiretroviral agents.
19.03.09
45.
Ropivacaine HCl Inj.2/5/7.5/10mg
For the production of local or regional anasthesia for surgery and for acute pain management.
19.03.09
46.
Butaphosphan 100g + Methyl Hydroxybenzoate 1gm + Cyanocobalamin50 gm Oral powder (Veterinary Drug)
As vitamin and phosphorous supplement for livestock, shirmp and fish.
19.03.09
47.
Fluticasone furoate Nasal spray 27.5mcg per spray
For the treatment of symptoms of allergic rhinitis.
19.03.09
48.
Octinoxate 7.5% + Avobenzone 2% + Oxybenzone 3% + Octocrylene 3%+ Zinc Oxide 2% lotion
A sunscreen lotion for prevention of sunburn skin
19.03.09
49.
Omeprazole 20/40mg + Sodium Bicarbonate 600mg+ Magnesium Hydroxide 700mg sachet
Additional Strength
19.03.09
50.
Ambroxol 30mg + Levo salbutamol 1mg+ Guiphenesin 50mg /5ml syrup
For the symptomatic relief of bronchospasm in bronchial asthma & chronic bronchitis
19.03.09
51.
Montelucast 4 mg+ Levocetrizine 2.5 mg tablet
Additional lower paedriatric dose
19.03.09
52.
Surgical Sealant
To be indicated for use in sealing suture lines along arterial and venous reconstructions.
26.03.09
53.
Lidocaine Patch 700mg in aqueous base. (50 mg per gram adhesive)
For the relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
26.03.09
54.
Bimatoprost Opthalmic solution 0.03%
For the treatment of hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
30.03.09
55.
Trabectedin powder for concentrate for solution for infusion 1 mg/ vial
For the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to recieve these agents.
30.03.09
56.
Acebrophylline Syrup 10mg/ml (Additional Indication)
For the treatment of children (age 6to 12years) with chronic obstructive pulmonary disease(COPD) and bronchial asthma.
30.03.09
57.
Mesalamine PR Tablets 1.2gm
For the induction of remission in patients with active, mild to moderate ulcerative colitis.
30.03.09
58.
Mycophenolate Mofetil Tablets 750mg Additional Strength
Same as approved
31.03.09
59.
Ketorolac Tromethamine Gel 2%w/w
For the treatment of muscle, joint and post-traumatic stress.
31.03.09
60.
Theophylline 400mg SR + Montelukast 10mg Tablet
For the treatment of patients with bronchial asthma
31.03.09
61.
Hyaluronic Acid Sodium Salt 0.2 gm + Silver Sulfadiazine 1.0 gm/25 gm tube Hyaluronic Acid Sodium Salt 50 mg + Silver Sulfadiazine 1.0 gm/ 100 gm gauze pads impregneted with cream.
For the treatment of wound of different etiology
31.03.09
62.
Telmisartan 80mg + Amlodipine 5mg tablet
Additional higher strength
31.03.09
63.
Hyaluronic Acid Sodium Salt
(i) Each 15gm tube contains: Hyaluronic Acid Sodium Salt 0.2gm/100gm
(ii) Sterile Gauze Pads impregnated with cream: Each gauze pad contains Hyaluronic Acid Sodium Salt 50/100mg
For the treatment of wound of different etiology
31.03.09
64.
Abatacept Injection 250mg/vial (additional indication)
For reducing signs and symptoms of moderately to severly active polyarticular juvenile idiopathic arthritis/juvenile rheumatoid arthritis in pediatric patients 6 years of age and older who have had an inadequate response to one or more DMARD's such as MTX
10.04.09
Cetrizine 10 mg + Ambroxol 75 mg SR Tablet
For symptomatic relief of productive cough associated with allergic rhinitis, when both anti-histamine and mucolytic agents are desired
13.04.2009
Ciclesonide 200mcg + Formoterol 6mcg + Tiotropium 9mcg MDI
Indicated as third line treatment of severe cases of COPD, when monotherapy and second line therapy with two drugs do not respond adequately.
13.04.2009
Each film coated bilayred tablet contains: Metoprolol 25mg/50mg + Chlorthalidone 12.5mg
For the tretament of patients with mild to modrate essential hypertension
13.04.2009
Milnacipran 25/50mg Caps (Addl. Indication)
For the management of fibromylagia.
15.04.2009
Lornoxicam SR 16mg Tabs
For the symptomatic treatment of pain and inflammation in patients of osteoarthritis & rheumatoid arthritis
25.04.2009
Palonosetron Hcl 0.075mg IV Inj (Addl. Strength)
Same as approved
25.04.2009
Each film coated bilayred tablet contains: Metoprolol 25mg/50mg + Chlorthalidone 6.25 mg /12.5mg
Additional strength
25.04.2009
Albendazole 400 mg + Ivermectin 6 mg tablet
For the treatment of intestinal helminthes and suppression of microfilaraemia especially with bancrofti infections
25.04.2009
Decitabine Lyophilized powder for injection 50mg/20ml vial
For treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes(refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk international Prognostic Scoring System groups.
25.04.2009
Retapamulin Ointment 1%
For the topical treatment of bacterial skin and skin structure infections:- Primary impetigo, secondarily infected traumatic lesions, secondarily infected dermatoses.
25.04.2009
Each ml contains Calamine 15% w/v + Zinc oxide 5% w/v + Bentonite 3% w/v+ Glycerin 5%w/v + Sodium citrate 0.05 % w/v lotion
For the tretament of pruritis and prickly heat
08.05.2009
Each 1000 ml of emulsion contains: Medium chain triglycerides 100 gm + Soya oil 80 gm + Omega-3 acid triglycerides 20 gm + egg lecithin 12 gm + Glycerl 25 gm + Sodium oleate 0.30 gm + Alpha -tocopherol 0.20 gm + Ascorbypalmitate 0.30 gm + Sodium hydroxide max. 0.06 gm + water for injection 784 gm emulsion for infusion
For the supply of fats, including essential omega-6 fatty acids and omega-3 fatty acids, as part of a parenteral nutrition regimen in adults if oral or enteral nutrition is impossible, inadequte or contraindicated.
14.05.2009
Sertaconazole Nitrate Powder 2% w/w & Lotion 2% w/v
For the topical treatment of the superficial fungal infections of the skin.
02.05.2009
Amlodipine Tablets 5mg/10mg (additional indication)
1. To reduce of fatal coronary heart disease and non-fatal myocardial infarction, and to reduce the risk of stroke. 2. To reduce the risk of coronary revascularization procedures and the need for hospitalization due to angina in patients with coronary artery disease.
02.05.2009
Clindamycin Phosphate Inj. 150mg/ml & Clindamycin HCl Capsules 150mg/300mg (additional indication)
Prophylaxis of infection in neck and head surgery
02.05.2009
Each 15 gm sachet contains: Lactulose 10 gm + Ispaghula husk 3.50 gm granules
For the treatment of chronic idiopathic constipation in adult patients only
16.05.2009
Sucralose
for use as sweetner in drug formulations
09.05.2009
CarvedilolTablets 3.125/6.25/12.5/25mg (additional indication)
To reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤ 40% (with or without symptomatic heart failure)
09.05.2009
Dexketoprofen 12.5 mg/25 mg + Paracetamol 500 mg film coated tablets
For the treatment of Acute musculoskeletal pain
18.05.2009
Pregabalin SR Tablet 150/300mg
For the treatment of peripheral neuropathic pain in adults
16.05.2009
Guaiphenesin ER Tablet 1200mg
For the treatment of productive cough accompanied by Phlegm
16.05.2009
Everolimus 5/10mg Tablets (Addl. Indication)
Treatment of advance renal cell carcinoma
16.05.2009
Nimesulide ER 200mg
( Additional Indication)
Acute pain in Orthopaedic, ENT, Dental and Post Operative condition
16.05.2009
Palonesetron Injection 0.25mg/5ml (Additional Indication)
For treatment of Post Operative Nausea & vomiting
16.05.2009
Bendamustine Hydrochloride Lyophilized powder Injection 100mg/ vial
For the treatment of patients with chronic lymphocytic leukemia.
16.05.09
Caffeine(as Citrate) 10mg / ml Injection
For the short term treatment of apnoea of prematurity of infants between 28 and < 33 weeks gestational age.
16.05.09
Perindopril arginine 2.5mg/5mg/10mg film coated tablet
For the treatment of arterial hypertension, congestive heart failure and coronary artery disease.
16.05.09
Each gm contains: Halobetasol 0.05% w/w + Mupirocin 2.0 % w/w gel
For the topical treatment of inflammatory dermatitis with secondry bacterial infection
16.05.09
Mometasone 0.1 % + Fusidic acid 2% cream/ointment
For the treatment of dermatoses where secondry bacterial and/or candidial infection is present
25.04.09
Thiocolchicoside 8 mg + Etoricoxib 60 mg tablets
Additional strength
25.04.09
Methadone Hydrochloride 5mg/10mg per ml syrup; 5mg/ 10mg/ 20mg / 40mg tablet
For the treatment of opiod dependence and in maintainence treatment for opioid dependence.
28.05.09
Trospium Chloride film coated tablet 20mg
For the treatment of overactive bladder with the symptoms of urge urinary incontinence, urgency, and urinary frequency.
28.05.09
Arformoterol (as Tartrate ) 15mcg / 2ml Inhalation Solution
For the long term, twice daily (morning and evening) maintainence treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
29.05.09
Zolmitriptan...5.0% w/v Benzalkonium Chloride NF ... 0.01% w/v Nasal spray
For the acute treatment of migraine with or without aura in adults.
29.05.09
Dexmedetomidine ( as HCl) 100mcg /ml Injection
For sedation of initially and mechanically ventilated patients during treatment in an intensive care setting.
29.05.09
Levetiracetam SR Tablet 500/750/1000mg
same as approved
2.05.2009
Glatiramer Acetate Injection (20mg/ ml) & Pre-filled syringe (20mg/ml)
For the reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.
3.06.2009
Yttrium-90 Microspheres Injection (Yttrium-90...3GBq (at the time of calibration) per vial)
For the treatment of unresectable metastatic liver tumors from primary colorectal cancer with intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine)
3.06.2009
Luliconazole Cream 1%
For the treatment of cutaneous mycosis viz. Tinea pedis, Tinea corporis, Tinea cruris.
3.06.2009
Magnesium Valporate Prolonged release tablet 600mg
1) For the treatment of generelized or partial seizures as monothreapy or adjunctive threapy. 2) For prophylaxis of migraine headache in adults. 3) For the treatment of manic episodes associated with bi polar disorders
4.06.2009
Tenofovir Disoproxil Fumerate 300mg
For the treatment of chronic Hepatitis B in adults
19.6.2009
Bosentan (as monohydrate) Tablets 62.5/125mg
For the treatment of pulmonary arterial hypertension (WHO Group I) in patients with WHO Class III or IV symptoms, to improve excercise ability and decrease the rate of clinical worsening.
23.6.2009
Lornoxicam 12 mg SR (additional strength)
same as approved
26.6.2009
Azithromycin SR Granules for oral suspension 2000mg
for the treatment for mild to moderate susceptible infection including RTI, uncomplicated skin/ skin structure, non gonococcal urethritis, cervicitis
26.6.2009
Metoprolol 50/50/25 mg + Atorvastatin 20/10/10 mg + Ramipril 10/5/2.5 mg capsules
As 2nd line treatment of patients with both essential hypertension and hypercholesterolemia who are not adequately controlled by combination of an anti-hypertensive with lipid lowering agent.
1.07.2009
Methyl Phenidate ER Tablet 10/20/30mg
For the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
10.07.2009
Dasatinib Tablets 100mg (addl. Strength)
same as approved
10.07.2009
Voglibose 0.2 mg + Metformin 500mg Tablets
As 2nd line treatment of type II Diabetes mellitus when diet, exercise and the single agent do not result in adequate glycemic control.
13.7.2009
Combipack of artesunate tablet and FDC Tablet of sulphadoxine + pyrimethamine Composition:
A. combipack of 1 stip of 3 tablets of artesunate 25 mg and 1 strip of 1 tablet of sulphadoxine 125mg+ pyrimethamine 6.25 mg
B. combipack of 1 stip of 3 tablets of artesunate 50 mg and 1 strip of 1 tablet of sulphadoxine 500mg+ pyrimethamine 25 mg
C. combipack of 1 stip of 3 tablets of artesunate 100 mg and 1 strip of 1 tablet of sulphadoxine 500mg+ pyrimethamine 25 mg D. combipack of 1 stip of 3 tablets of artesunate 200 mg and 1 strip of 1 tablet of sulphadoxine 500mg+ pyrimethamine 25 mg.
For the treatment of P. falciparum resistant malaria patients
15.7.2009
Milnacipran 100mg (additional Strength)
same as approved
16.7.2009
Rifaximin 400mg (additional Indication)
For the treatment of hepatic encephalopathy
18.7.2009
Nevirapine tablet 50 mg for oral suspension mg
For the treatment of HIV infection in combination with other anti retro viral agents
18.7.2009
Desvenlafaxine (as Succinate) ER Tablets 50mg/100mg
For the treatment of major depressive disorder (MDD)
18.7.2009
Posaconazole Oral Suspension 40mg/ml
For the treatment of oropharyngeal candidiasis, including oropharyngeal candidiasis refractory to itraconazole and/or fluconazole. For prophylaxis of invasive Aspergillus and Candida infections in patients, 13 years of age and older, who are at high risk of developing these infections due to being severly immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy.
18.7.2009
Caffeine Citrate 20mg / ml (equivalent to 10mg of Caffeine base) Oral Solution (Addl. Dosage form)
same as approved
18.7.2009
Amphotericin B Emulsion 5mg/ml (Addl. Indication)
Febrile Neutropenia in cancer patients
18.7.2009
Hydroxy ethyl starch 10% Solution for infusion
For the treatment of imminent or manifest hypovolemia and shock.
18.7.2009
Naratriptan (as HCl) Tablets 1/ 2.5mg
For the acute treatment of migraine with or without aura in adults.
18.7.2009
Colistimethate Sodium powder for solution for injection/infusion 500000IU and 2000000IU (additional Strength)
same as approved
20.7.2009
Simvastatin 20 mg + Ramipril 5mg + Atenolol 50 mg + HCTZ 12.5 mg + Aspirin 100 mg (EC Pellets) Capsules
For secondary prevention of coronory heart disease/stroke in patients where use of such combination is appropriate
21.7.2009
Colistimethate Sodium powder for solution for inhalation 500000IU/1000000IU/2000000IU
Treatment by inhalation of Pseudomonas aeruginosa lung infection in patients with cystic fibrosis
28.7.2009
Ramipril MR capsule 10mg
For the treatment of hypertension/ cardiac failure and myocardial infarction
30.7.2009
Abacavir Sulfate Tablet 60mg
For the treatment of HIV-1 infection in combination with other antiretroviral agents
1.08.2009
Zoledronic Acid Solution for Infusion Addl. Indication
Prevention of clinical fractures after hip fracture in men and women
1.08.2009
Sumatriptan 85 mg + Naproxen 500 mg Tablets
Additional Strength for the treatment of migraine
3.08.2009
Aceclofenac(100mg) + Thiocolchicoside ( 8 mg) tablets
For the treatment of acute inflammation conditions associated with spasm in adults only
3.08.2009
Oxcarbazepine 150/300/600mg Tablet (Addl. Indication
Treatment of generalized tonic-clonic seizures in adults and children
13.08.2009
Ofloxacin 2mg + Ornidazole 5 mg per ml Infusion
for the treatment of diarrhoea of mixed infection in adult patients
17.08.2009
Clozapine Tablet200mg (Addl. Strength)
Indicated in the management of Schizophrenic patients
19.08.2009
Oxymetazoline Hydrochloride Nasal Spray50mcg/0.05%w/w
Is indicated for the relief of stuffy,running nose associated with colds and influenza, also post nasal drip, sinusitis.
19.08.2009
Enoxaparin Sodium Injection (Addl.Indication)
Treatment of acute ST-segment elevation myocardial infarction including patients to be managed medically or with subsequent percuaneous coronary intervention (PCI)
19.08.2009
Fluvoxamine Maleate100/150mg ER Tablets
For the treatment of obsessive compulsive disorder (OCD)and depression
19.08.2009
Lidocaine Lozenges 200/300mg (Addl. Indication)
For single agent anesthesia in procedure involving the introduction of instrument & tubes into respiratory tract.
19.08.2009
Risperidone long acting injection (Addl. Indication)
Indicated as monotherapy or as adjunctive therapy in lithium or valproate for the maintenance treatment of Bipolar-1 disorder.
29.08.2009
Exemestane 25mg Tablet (Addl. Indication)
Indicated for adjuvant treatment of Post Menopausal Women with estrogen receptor positive early breast cancer who have received two-three year of tamoxifen and are switched to exemestane for completion of total of five years of adjuvant hormonal therapy.
29.08.2009
Artesunate (25/50/100mg) + Amodiaquine (67.5 mg/135/270mg) bilayerd Tablets
For the treatment of uncomplicated malaria due to plasmodium falciparum strain in various age groups
01.09.2009
Ezetimibe 10 mg + Fenofibrate 145 mg Film coated tablets
For the treatment of combined hyperlipidemia in patients with normal hepatic and renal function
01.09.2009
Buprenorphine Transdermal Patch Each Transdermal Patch having an area of 6.25cm², 12.5cm², and 25cm²contains: Buprenorphine…5mg/10mg/20mg having release rate of 5mcg, 10mcg, 20mcg Buprenorphine per hour respectively (over a period of 7 days).
For the treatment of severe opioid responsive painconditions which are not adequately responding to non-opioid analgesics.For Hospital supply only.
03.09.09
Trospium Chloride ER Capsules 60 mg
For the treatment of overactive bladder with the symptoms of urge urinary incontinence, urgency and urinary frequency.
04.09.2009
Metoclopramide (as HCl) 200mg / 400mg per ml Intranasal Solution
For the treatment of nausea and vomiting.
09.09.09
Isosorbibe 20 mg + Hydralazine 37.5 mg tablets
For the treatment of heart failure as an adjunct to standard therapy in patients to improve survival, to prolong time to hospitalization for heart failure and to improve patients reported functional status.
18.09.2009
Cefixime 200 mg + Dicloxacillin ER 500 mg Tablets
For the treatment of adult patients with Upper and Lower respiratory tract infections, skin and soft tissue infections
22.09.2009
Chlorthalidone Tablet 6.25mg
For the treatment of mild to moderate hypetension.
03.10.09
Cefovecin( as sodium) 80mg/ ml Lyophilised powder for injection (Veterinary)
For the treatment of skin bacterial infections in dogs and cats.
03.10.09
Imidacloprid 10% + Moxidectin 1.0% & 2.5% Topical solution (Veterinary) Each pippette contains: (a) 0.4ml, 1.0ml, 2.5ml, 4ml of 10% Imidacloprid and 1.0% moxidectin (b) 0.4ml, 0.8ml of 10% Imidacloprid and 2.5% moxidectin
For the treatment and prevention of flea infestations, prevention of heartworm disease and treatment of infections with gastrointestinal nematodes in dogs and cats.
03.10.09
Isoflupredone AcetateSuspension for Injection (2mg per ml) (For Veterinary)
For the glucocorticoid, anti-inflammatory or supportive therapy to cattle suffering from conditions such as:(1) Overwhelming infections with severe toxicity. (2) Bovine ketosis.(3) Musculoskeletal conditions.(4) Shock.(5) Parturient paresis (supportive stress therapy for milk fever).
03.10.09
Saxagliptin (as HCl) 2.5mg/ 5mg Tablets
As an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus. (It should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.
24.10.09
Calcipotriol Gel 0.005% (additional dosage form)
For the treatment of moderate plaque psoriasis in adults
3.10.2009
Lamotrigine MR Tablets 150mg (Addl. Strength)
same as approved
3.10.2009
Metoprolol Tartrate ER Tablet 75mg (additional strength)
same as approved
3.10.2009
Valganciclovir Powder for Oral Solution 50mg/ml
For the treatment of cytomegalovirus (CMV) retinitis in AIDS patients and for prevention of CMV disease in solid organ transplant patients at high risk
9.10.2009
Dexketoprofen Trometamol Gel 12.5mg/gm
For the painful and inflammatory conditions associated with joints, tendons, ligaments and muscle
13.10.2009
Donepezil Hydrochloride Orodispersible Tablet 5mg/10mg
For the treatment of mild to moderate severe Alzheimer's Dementia
15.10.2009
Dexketoprofen Trometamol Injection 50mg/2ml
Symptomatic treatment of acute pain of moderate to severe intensity, when oral administration is not appropriate such as post-operative pain, renal colic and low back pain.
22.10.2009
Bromocriptine Mesylate Tablet IP 0.8mg, (additional Indication)
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
22.10.2009
Levosulpride ER Tablet 100/150/200mg
For the treatment of depression and schizophrenia in adults
27.10.2009
Ambroxol 30 mg+ Terbutaline 2.5 mg + Guaiphenesin 100mg + Menthol 2.5 mg per 5 ml syrup
Additional strength
27.10.2009
Propofol 10 mg+ Lignocaine 2.5 mg per ml injection
Additional strength
27.10.2009
Mecobalamin 750 mg + Pyridoxine Hydrochloride1.5 mg + Nicotinamide 45 mg tablets
For the treatment of diabetic neuropathy
27.10.2009
Olmesartan (20/40mg )+ Atorvastatin 5/10/20mg film coated tablets
For the treatment of co-existing essential hypertension and hyperlipidemia in adult patients
27.10.2009
Reference: http://cdsco.nic.in/listofdrugapprovedmain.html
Drug Name
Indication
Approval Date
1.
Zoledronic Acid Injection 5mg/100ml (Addl. Indication)
For the treatement of osteoporosis in post-menopausal women and in men who are at increased risk of fracture, including those with a recent low-trauma hip fracture.
07.01.09
2.
Misoprostol Tablet 600mcg
Addl. Strength
09.01.09
3.
Acebrophylline Syrup 10mg/ ml
For the treatement of adult patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma.
09.01.09
4.
Selamectin Tropical solution (for verterinary use.) 60mg/120mg per ml
(I) For the treatement and lasting prevention of flea infestations,treatment and control of flea allergy dermatitis, prevention of heartworm disease,treatement and prevention of ear mites in dogs and cats;
(II) For the treatement and prevention of sarcoptic mange, roundworms and for control of tick infestations in dogs.
09.01.09
5.
Methylcobalamin1500mcg + Calcium 200mg + Calcitriol 0.25mcg + Folic Acid1.5mg + Pyridoxine3mg Capsules
For the treatment of vitamin deficiency states in adults
14.01.09
6.
Metoprolol tartrate tablets 50 mg (Addl. Indication)
Adjunct to the treatement of Hyperthyroidism
14.01.09
7.
Cinacalet (as HCl) Tablet 30/60/90mg
For the treatment of secondary hyper parathyroidism in patients with chronic kidney diseases (CKD) on dialysis and for hypercalcemia in patients with parathyroid carcinoma
14.01.09
8.
Mycophenolate mofetil Capsules 250mg, Tablets 500mg, Oral suspension 200mg/ml (addl. Indication)
For the prophylaxis of acute organ rejection in patients recieving allogenic hepatic transplantation.
23.01.09
9.
Liquid Paraffin1.25ml + Milk of Magnesia 3.75ml + Sodium Picosulphate 3.33mg per 5ml
For symptomatic treatment of constipation in adults
29.01.09
10.
Ranolazine 1000mg ER Tabs (Additional Strength)
Same as approved
31.01.09
11.
Hyaluronic acid (cross linked) Pre-filled syringe 18mg/0.6ml and 24mg/0.8ml
For intradermal implantation and facial soft tissue augmentation
31.01.09
12.
Caspofungin acetate Injection (Addl. Indication)
For use in following: (I) Empirical therapy for presumed fungal infections in febrile neutropenic patients.
(II) Treatment of Candidemia and the following Candida infections: Intra-abdominal abscesses, Peritonitis and Pleural space infections.
(III) Treatment of Esophageal Candidiasis.
(IV) Treatment of invasive Aspergillosis in patients who are refractory to or intolerant of other therapies (i.e, amphotericin B, lipid formulations of amphotericin B, and/or itraconazole)
31.01.09
13.
Micafungin ( as sodium) Powder for solution for infusion 50mg / vial
For the treatment of patients with candidemia, acute disseminated candidiasis, candida peritonitis, abscess and esophageal candidiasis. For the prophylaxis of Candida infection in patients undergoing hematopoietic stem cell transplantation (HSCT)
31.01.09
14.
Loteprednol Etabonate Nasal spray 0.1% w/v
For prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis.
31.01.09
15.
Rasagiline (as mesylate ) Tablet 0.5mg/1mg
For the tratment of signs and symptoms of idiopathic Parkinson's disease as intial monotherapy and as an addition to levodopa.
31.01.09
16.
Nicotine Polacrilex Gum 2mg & 4mg (Addl. Indication)
To reduce the withdrawal symptoms, including nicotine craving, associated with quitting the smoking and quitting chewed tobacco and guthka containing tobacco.
03.02.09
17.
Closantel Injection100mg/ ml (for verterinary use.)
For the infestation of trematodes, nematodes, cestodes and arthropods of domestic animals, including milch and other food producing animals.
05.02.09
18.
Lornoxicam 4mg + Paracetamol 500mg film coated tablets
For the short term use in acute painful & inflammatory conditions in adults
05.02.09
19.
Cetrimide15% w/v + Chlorhexidine Gluconate 7.5% v/v + Isopropyl Alcohol 7.5% v/v Concentrate Solution
For cleansing of physically contaminated wounds and for pre-operative disinfection
09.02.09
20.
Ketoconazole 2% w/v + Prepared Coal Tar 2% w/v (I.P. 1966) Solution
For the treatment of dandruff
09.02.09
21.
Doripenem (as monohydrate) Injection 250mg/500mg
For the treatment of nosocomial pneumonia in adults.
16.02.09
22.
Halobetasol Scalp Approved 0.05% w/v
For the relief of inflammatory and puritic manifestation of corticosteroid respensive dermatosis
18.02.09
23.
Nicotine (as Polacrilex) Lozenges 2mg & 4mg
To reduce the withdrawal symptoms, including nicotine craving, associated with quitting the smoking and quitting chewed tobacco and guthka containing tobacco.
18.02.09
24.
Tranexamic Acid Tab SR 750mg
For the treatment of menorrhagia
20.02.09
25.
Betahistine Mesilate Tablet 6mg/12mg
For the treatment of dizziness and feeling of dizziness resulting from Meniere's disease, Meniere's syndrome and vertigo.
20.02.09
26.
Abatacept Injection 250mg/vial (Addl. Indication)
In moderately to severly active rheumatoid arithritis in adults and may be used as monotherapy or concomitantly with DMARD's other than TNF antagonists
20.02.09
27.
Anidulafungin Injection (Lyophilized powder) 50mg/100mg per vial
For the treatment of invasive candidiasis including candidemia and esophageal candidiasis in adult patients.
23.02.09
28.
Hydroquinone 2%+ Tretinoin 0.05% + Hydrocortisone1%Cream
For the treatment of patients with skin hyperpigmentation
23.02.09
29.
Doxyphylline 400 mg + Terbutaline 5mg tablets
For the treatment of asthma and chronic obstructive pulmonary disease in adult patients only
23.02.09
30.
Hydroquinone 20mg + Tretinoin 0.25mg + Fluocinolone Acetonide 0.1mg per gm Cream
For the treatment of melasma of face in adults
23.02.09
31.
Ketoconazole 2% + Zinc Pyrithone 1% Lotion
For the treatment of pityriasis and dandruff of the scalp
23.02.09
32.
Lamivudine 30mg + Zidovudine 60mg + Nevirapine 50mg Oral Suspension (Tablets for oral Suspension)
For the treatment of HIV patients
23.02.09
33.
Glibenclamide 5mg + Pioglitazone 15mg + Metformin500mg film coated tablets
As 3rd line treatment of type II diabetes mellitus when diet, exercise and the single agents and the second line therapy with two drugs do not result in adequate glycemic control
23.02.09
34.
Aceclofenac 100mg + Tizanidine 2mg film coated tablets
For the treatment of acute low back pain in adult patients only
23.02.09
35.
Octinoxate 7.5% + Avobenzone 3% + Oxybenzone 3% + Titanium dioxide 2% lotion
As sunscreen lotion for prevention of sunburn skin
23.02.09
36.
Cetrizine 5/10mg + Ambroxol 30mg per 5ml syrup
For the symptomatic relief of productive cough associated with allergic rhinitis, when both anti-histamine and mucolytic agents are desired
23.02.09
37.
Lidocaine Lozenges 200/300mg
For single agent anesthesia in upper gastro intestinal endoscopy.
26.02.09
38.
Calamine 8% + Liquid Paraffin10% lotion
As antipruritic and smoothening agent
26.02.09
39.
Nifedipine 0.3% + Lidocaine1.5% cream
For the treatment of anal fissures
26.02.09
40.
Quinapril 20mg + HCTZ 25mg film coated tablet
For the treatment of mild to moderate hypertension in adult patients (in whom combination therapy is appropriate) who have been stabilized on the individual components given in the same proportion
26.02.09
41.
Levodopa 100/100/250 + Carbidopa 10/25/25mg mouth dissolving tablet
For the symptomatic symptoms of idiopathic Parkinson's Disease
04.03.09
42.
Paliperidone ER Tablets 1.5mg
Addl. Strength
04.03.09
43.
Losartan 100mg+ HCTZ 25 mg tablet
Additional higher strength
16.03.09
44.
Darunavir(as ethanolate) Tablet 300mg
For the treatment of human immunodeficiency virus (HIV) infection in antiretroviral treatment experienced adult patients, such as those patients with HIV-1 strains resistant to more than one protease inhibitor when co-administered with 100mg ritonavir, and with other antiretroviral agents.
19.03.09
45.
Ropivacaine HCl Inj.2/5/7.5/10mg
For the production of local or regional anasthesia for surgery and for acute pain management.
19.03.09
46.
Butaphosphan 100g + Methyl Hydroxybenzoate 1gm + Cyanocobalamin50 gm Oral powder (Veterinary Drug)
As vitamin and phosphorous supplement for livestock, shirmp and fish.
19.03.09
47.
Fluticasone furoate Nasal spray 27.5mcg per spray
For the treatment of symptoms of allergic rhinitis.
19.03.09
48.
Octinoxate 7.5% + Avobenzone 2% + Oxybenzone 3% + Octocrylene 3%+ Zinc Oxide 2% lotion
A sunscreen lotion for prevention of sunburn skin
19.03.09
49.
Omeprazole 20/40mg + Sodium Bicarbonate 600mg+ Magnesium Hydroxide 700mg sachet
Additional Strength
19.03.09
50.
Ambroxol 30mg + Levo salbutamol 1mg+ Guiphenesin 50mg /5ml syrup
For the symptomatic relief of bronchospasm in bronchial asthma & chronic bronchitis
19.03.09
51.
Montelucast 4 mg+ Levocetrizine 2.5 mg tablet
Additional lower paedriatric dose
19.03.09
52.
Surgical Sealant
To be indicated for use in sealing suture lines along arterial and venous reconstructions.
26.03.09
53.
Lidocaine Patch 700mg in aqueous base. (50 mg per gram adhesive)
For the relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
26.03.09
54.
Bimatoprost Opthalmic solution 0.03%
For the treatment of hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
30.03.09
55.
Trabectedin powder for concentrate for solution for infusion 1 mg/ vial
For the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to recieve these agents.
30.03.09
56.
Acebrophylline Syrup 10mg/ml (Additional Indication)
For the treatment of children (age 6to 12years) with chronic obstructive pulmonary disease(COPD) and bronchial asthma.
30.03.09
57.
Mesalamine PR Tablets 1.2gm
For the induction of remission in patients with active, mild to moderate ulcerative colitis.
30.03.09
58.
Mycophenolate Mofetil Tablets 750mg Additional Strength
Same as approved
31.03.09
59.
Ketorolac Tromethamine Gel 2%w/w
For the treatment of muscle, joint and post-traumatic stress.
31.03.09
60.
Theophylline 400mg SR + Montelukast 10mg Tablet
For the treatment of patients with bronchial asthma
31.03.09
61.
Hyaluronic Acid Sodium Salt 0.2 gm + Silver Sulfadiazine 1.0 gm/25 gm tube Hyaluronic Acid Sodium Salt 50 mg + Silver Sulfadiazine 1.0 gm/ 100 gm gauze pads impregneted with cream.
For the treatment of wound of different etiology
31.03.09
62.
Telmisartan 80mg + Amlodipine 5mg tablet
Additional higher strength
31.03.09
63.
Hyaluronic Acid Sodium Salt
(i) Each 15gm tube contains: Hyaluronic Acid Sodium Salt 0.2gm/100gm
(ii) Sterile Gauze Pads impregnated with cream: Each gauze pad contains Hyaluronic Acid Sodium Salt 50/100mg
For the treatment of wound of different etiology
31.03.09
64.
Abatacept Injection 250mg/vial (additional indication)
For reducing signs and symptoms of moderately to severly active polyarticular juvenile idiopathic arthritis/juvenile rheumatoid arthritis in pediatric patients 6 years of age and older who have had an inadequate response to one or more DMARD's such as MTX
10.04.09
Cetrizine 10 mg + Ambroxol 75 mg SR Tablet
For symptomatic relief of productive cough associated with allergic rhinitis, when both anti-histamine and mucolytic agents are desired
13.04.2009
Ciclesonide 200mcg + Formoterol 6mcg + Tiotropium 9mcg MDI
Indicated as third line treatment of severe cases of COPD, when monotherapy and second line therapy with two drugs do not respond adequately.
13.04.2009
Each film coated bilayred tablet contains: Metoprolol 25mg/50mg + Chlorthalidone 12.5mg
For the tretament of patients with mild to modrate essential hypertension
13.04.2009
Milnacipran 25/50mg Caps (Addl. Indication)
For the management of fibromylagia.
15.04.2009
Lornoxicam SR 16mg Tabs
For the symptomatic treatment of pain and inflammation in patients of osteoarthritis & rheumatoid arthritis
25.04.2009
Palonosetron Hcl 0.075mg IV Inj (Addl. Strength)
Same as approved
25.04.2009
Each film coated bilayred tablet contains: Metoprolol 25mg/50mg + Chlorthalidone 6.25 mg /12.5mg
Additional strength
25.04.2009
Albendazole 400 mg + Ivermectin 6 mg tablet
For the treatment of intestinal helminthes and suppression of microfilaraemia especially with bancrofti infections
25.04.2009
Decitabine Lyophilized powder for injection 50mg/20ml vial
For treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes(refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk international Prognostic Scoring System groups.
25.04.2009
Retapamulin Ointment 1%
For the topical treatment of bacterial skin and skin structure infections:- Primary impetigo, secondarily infected traumatic lesions, secondarily infected dermatoses.
25.04.2009
Each ml contains Calamine 15% w/v + Zinc oxide 5% w/v + Bentonite 3% w/v+ Glycerin 5%w/v + Sodium citrate 0.05 % w/v lotion
For the tretament of pruritis and prickly heat
08.05.2009
Each 1000 ml of emulsion contains: Medium chain triglycerides 100 gm + Soya oil 80 gm + Omega-3 acid triglycerides 20 gm + egg lecithin 12 gm + Glycerl 25 gm + Sodium oleate 0.30 gm + Alpha -tocopherol 0.20 gm + Ascorbypalmitate 0.30 gm + Sodium hydroxide max. 0.06 gm + water for injection 784 gm emulsion for infusion
For the supply of fats, including essential omega-6 fatty acids and omega-3 fatty acids, as part of a parenteral nutrition regimen in adults if oral or enteral nutrition is impossible, inadequte or contraindicated.
14.05.2009
Sertaconazole Nitrate Powder 2% w/w & Lotion 2% w/v
For the topical treatment of the superficial fungal infections of the skin.
02.05.2009
Amlodipine Tablets 5mg/10mg (additional indication)
1. To reduce of fatal coronary heart disease and non-fatal myocardial infarction, and to reduce the risk of stroke. 2. To reduce the risk of coronary revascularization procedures and the need for hospitalization due to angina in patients with coronary artery disease.
02.05.2009
Clindamycin Phosphate Inj. 150mg/ml & Clindamycin HCl Capsules 150mg/300mg (additional indication)
Prophylaxis of infection in neck and head surgery
02.05.2009
Each 15 gm sachet contains: Lactulose 10 gm + Ispaghula husk 3.50 gm granules
For the treatment of chronic idiopathic constipation in adult patients only
16.05.2009
Sucralose
for use as sweetner in drug formulations
09.05.2009
CarvedilolTablets 3.125/6.25/12.5/25mg (additional indication)
To reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤ 40% (with or without symptomatic heart failure)
09.05.2009
Dexketoprofen 12.5 mg/25 mg + Paracetamol 500 mg film coated tablets
For the treatment of Acute musculoskeletal pain
18.05.2009
Pregabalin SR Tablet 150/300mg
For the treatment of peripheral neuropathic pain in adults
16.05.2009
Guaiphenesin ER Tablet 1200mg
For the treatment of productive cough accompanied by Phlegm
16.05.2009
Everolimus 5/10mg Tablets (Addl. Indication)
Treatment of advance renal cell carcinoma
16.05.2009
Nimesulide ER 200mg
( Additional Indication)
Acute pain in Orthopaedic, ENT, Dental and Post Operative condition
16.05.2009
Palonesetron Injection 0.25mg/5ml (Additional Indication)
For treatment of Post Operative Nausea & vomiting
16.05.2009
Bendamustine Hydrochloride Lyophilized powder Injection 100mg/ vial
For the treatment of patients with chronic lymphocytic leukemia.
16.05.09
Caffeine(as Citrate) 10mg / ml Injection
For the short term treatment of apnoea of prematurity of infants between 28 and < 33 weeks gestational age.
16.05.09
Perindopril arginine 2.5mg/5mg/10mg film coated tablet
For the treatment of arterial hypertension, congestive heart failure and coronary artery disease.
16.05.09
Each gm contains: Halobetasol 0.05% w/w + Mupirocin 2.0 % w/w gel
For the topical treatment of inflammatory dermatitis with secondry bacterial infection
16.05.09
Mometasone 0.1 % + Fusidic acid 2% cream/ointment
For the treatment of dermatoses where secondry bacterial and/or candidial infection is present
25.04.09
Thiocolchicoside 8 mg + Etoricoxib 60 mg tablets
Additional strength
25.04.09
Methadone Hydrochloride 5mg/10mg per ml syrup; 5mg/ 10mg/ 20mg / 40mg tablet
For the treatment of opiod dependence and in maintainence treatment for opioid dependence.
28.05.09
Trospium Chloride film coated tablet 20mg
For the treatment of overactive bladder with the symptoms of urge urinary incontinence, urgency, and urinary frequency.
28.05.09
Arformoterol (as Tartrate ) 15mcg / 2ml Inhalation Solution
For the long term, twice daily (morning and evening) maintainence treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
29.05.09
Zolmitriptan...5.0% w/v Benzalkonium Chloride NF ... 0.01% w/v Nasal spray
For the acute treatment of migraine with or without aura in adults.
29.05.09
Dexmedetomidine ( as HCl) 100mcg /ml Injection
For sedation of initially and mechanically ventilated patients during treatment in an intensive care setting.
29.05.09
Levetiracetam SR Tablet 500/750/1000mg
same as approved
2.05.2009
Glatiramer Acetate Injection (20mg/ ml) & Pre-filled syringe (20mg/ml)
For the reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.
3.06.2009
Yttrium-90 Microspheres Injection (Yttrium-90...3GBq (at the time of calibration) per vial)
For the treatment of unresectable metastatic liver tumors from primary colorectal cancer with intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine)
3.06.2009
Luliconazole Cream 1%
For the treatment of cutaneous mycosis viz. Tinea pedis, Tinea corporis, Tinea cruris.
3.06.2009
Magnesium Valporate Prolonged release tablet 600mg
1) For the treatment of generelized or partial seizures as monothreapy or adjunctive threapy. 2) For prophylaxis of migraine headache in adults. 3) For the treatment of manic episodes associated with bi polar disorders
4.06.2009
Tenofovir Disoproxil Fumerate 300mg
For the treatment of chronic Hepatitis B in adults
19.6.2009
Bosentan (as monohydrate) Tablets 62.5/125mg
For the treatment of pulmonary arterial hypertension (WHO Group I) in patients with WHO Class III or IV symptoms, to improve excercise ability and decrease the rate of clinical worsening.
23.6.2009
Lornoxicam 12 mg SR (additional strength)
same as approved
26.6.2009
Azithromycin SR Granules for oral suspension 2000mg
for the treatment for mild to moderate susceptible infection including RTI, uncomplicated skin/ skin structure, non gonococcal urethritis, cervicitis
26.6.2009
Metoprolol 50/50/25 mg + Atorvastatin 20/10/10 mg + Ramipril 10/5/2.5 mg capsules
As 2nd line treatment of patients with both essential hypertension and hypercholesterolemia who are not adequately controlled by combination of an anti-hypertensive with lipid lowering agent.
1.07.2009
Methyl Phenidate ER Tablet 10/20/30mg
For the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
10.07.2009
Dasatinib Tablets 100mg (addl. Strength)
same as approved
10.07.2009
Voglibose 0.2 mg + Metformin 500mg Tablets
As 2nd line treatment of type II Diabetes mellitus when diet, exercise and the single agent do not result in adequate glycemic control.
13.7.2009
Combipack of artesunate tablet and FDC Tablet of sulphadoxine + pyrimethamine Composition:
A. combipack of 1 stip of 3 tablets of artesunate 25 mg and 1 strip of 1 tablet of sulphadoxine 125mg+ pyrimethamine 6.25 mg
B. combipack of 1 stip of 3 tablets of artesunate 50 mg and 1 strip of 1 tablet of sulphadoxine 500mg+ pyrimethamine 25 mg
C. combipack of 1 stip of 3 tablets of artesunate 100 mg and 1 strip of 1 tablet of sulphadoxine 500mg+ pyrimethamine 25 mg D. combipack of 1 stip of 3 tablets of artesunate 200 mg and 1 strip of 1 tablet of sulphadoxine 500mg+ pyrimethamine 25 mg.
For the treatment of P. falciparum resistant malaria patients
15.7.2009
Milnacipran 100mg (additional Strength)
same as approved
16.7.2009
Rifaximin 400mg (additional Indication)
For the treatment of hepatic encephalopathy
18.7.2009
Nevirapine tablet 50 mg for oral suspension mg
For the treatment of HIV infection in combination with other anti retro viral agents
18.7.2009
Desvenlafaxine (as Succinate) ER Tablets 50mg/100mg
For the treatment of major depressive disorder (MDD)
18.7.2009
Posaconazole Oral Suspension 40mg/ml
For the treatment of oropharyngeal candidiasis, including oropharyngeal candidiasis refractory to itraconazole and/or fluconazole. For prophylaxis of invasive Aspergillus and Candida infections in patients, 13 years of age and older, who are at high risk of developing these infections due to being severly immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy.
18.7.2009
Caffeine Citrate 20mg / ml (equivalent to 10mg of Caffeine base) Oral Solution (Addl. Dosage form)
same as approved
18.7.2009
Amphotericin B Emulsion 5mg/ml (Addl. Indication)
Febrile Neutropenia in cancer patients
18.7.2009
Hydroxy ethyl starch 10% Solution for infusion
For the treatment of imminent or manifest hypovolemia and shock.
18.7.2009
Naratriptan (as HCl) Tablets 1/ 2.5mg
For the acute treatment of migraine with or without aura in adults.
18.7.2009
Colistimethate Sodium powder for solution for injection/infusion 500000IU and 2000000IU (additional Strength)
same as approved
20.7.2009
Simvastatin 20 mg + Ramipril 5mg + Atenolol 50 mg + HCTZ 12.5 mg + Aspirin 100 mg (EC Pellets) Capsules
For secondary prevention of coronory heart disease/stroke in patients where use of such combination is appropriate
21.7.2009
Colistimethate Sodium powder for solution for inhalation 500000IU/1000000IU/2000000IU
Treatment by inhalation of Pseudomonas aeruginosa lung infection in patients with cystic fibrosis
28.7.2009
Ramipril MR capsule 10mg
For the treatment of hypertension/ cardiac failure and myocardial infarction
30.7.2009
Abacavir Sulfate Tablet 60mg
For the treatment of HIV-1 infection in combination with other antiretroviral agents
1.08.2009
Zoledronic Acid Solution for Infusion Addl. Indication
Prevention of clinical fractures after hip fracture in men and women
1.08.2009
Sumatriptan 85 mg + Naproxen 500 mg Tablets
Additional Strength for the treatment of migraine
3.08.2009
Aceclofenac(100mg) + Thiocolchicoside ( 8 mg) tablets
For the treatment of acute inflammation conditions associated with spasm in adults only
3.08.2009
Oxcarbazepine 150/300/600mg Tablet (Addl. Indication
Treatment of generalized tonic-clonic seizures in adults and children
13.08.2009
Ofloxacin 2mg + Ornidazole 5 mg per ml Infusion
for the treatment of diarrhoea of mixed infection in adult patients
17.08.2009
Clozapine Tablet200mg (Addl. Strength)
Indicated in the management of Schizophrenic patients
19.08.2009
Oxymetazoline Hydrochloride Nasal Spray50mcg/0.05%w/w
Is indicated for the relief of stuffy,running nose associated with colds and influenza, also post nasal drip, sinusitis.
19.08.2009
Enoxaparin Sodium Injection (Addl.Indication)
Treatment of acute ST-segment elevation myocardial infarction including patients to be managed medically or with subsequent percuaneous coronary intervention (PCI)
19.08.2009
Fluvoxamine Maleate100/150mg ER Tablets
For the treatment of obsessive compulsive disorder (OCD)and depression
19.08.2009
Lidocaine Lozenges 200/300mg (Addl. Indication)
For single agent anesthesia in procedure involving the introduction of instrument & tubes into respiratory tract.
19.08.2009
Risperidone long acting injection (Addl. Indication)
Indicated as monotherapy or as adjunctive therapy in lithium or valproate for the maintenance treatment of Bipolar-1 disorder.
29.08.2009
Exemestane 25mg Tablet (Addl. Indication)
Indicated for adjuvant treatment of Post Menopausal Women with estrogen receptor positive early breast cancer who have received two-three year of tamoxifen and are switched to exemestane for completion of total of five years of adjuvant hormonal therapy.
29.08.2009
Artesunate (25/50/100mg) + Amodiaquine (67.5 mg/135/270mg) bilayerd Tablets
For the treatment of uncomplicated malaria due to plasmodium falciparum strain in various age groups
01.09.2009
Ezetimibe 10 mg + Fenofibrate 145 mg Film coated tablets
For the treatment of combined hyperlipidemia in patients with normal hepatic and renal function
01.09.2009
Buprenorphine Transdermal Patch Each Transdermal Patch having an area of 6.25cm², 12.5cm², and 25cm²contains: Buprenorphine…5mg/10mg/20mg having release rate of 5mcg, 10mcg, 20mcg Buprenorphine per hour respectively (over a period of 7 days).
For the treatment of severe opioid responsive painconditions which are not adequately responding to non-opioid analgesics.For Hospital supply only.
03.09.09
Trospium Chloride ER Capsules 60 mg
For the treatment of overactive bladder with the symptoms of urge urinary incontinence, urgency and urinary frequency.
04.09.2009
Metoclopramide (as HCl) 200mg / 400mg per ml Intranasal Solution
For the treatment of nausea and vomiting.
09.09.09
Isosorbibe 20 mg + Hydralazine 37.5 mg tablets
For the treatment of heart failure as an adjunct to standard therapy in patients to improve survival, to prolong time to hospitalization for heart failure and to improve patients reported functional status.
18.09.2009
Cefixime 200 mg + Dicloxacillin ER 500 mg Tablets
For the treatment of adult patients with Upper and Lower respiratory tract infections, skin and soft tissue infections
22.09.2009
Chlorthalidone Tablet 6.25mg
For the treatment of mild to moderate hypetension.
03.10.09
Cefovecin( as sodium) 80mg/ ml Lyophilised powder for injection (Veterinary)
For the treatment of skin bacterial infections in dogs and cats.
03.10.09
Imidacloprid 10% + Moxidectin 1.0% & 2.5% Topical solution (Veterinary) Each pippette contains: (a) 0.4ml, 1.0ml, 2.5ml, 4ml of 10% Imidacloprid and 1.0% moxidectin (b) 0.4ml, 0.8ml of 10% Imidacloprid and 2.5% moxidectin
For the treatment and prevention of flea infestations, prevention of heartworm disease and treatment of infections with gastrointestinal nematodes in dogs and cats.
03.10.09
Isoflupredone AcetateSuspension for Injection (2mg per ml) (For Veterinary)
For the glucocorticoid, anti-inflammatory or supportive therapy to cattle suffering from conditions such as:(1) Overwhelming infections with severe toxicity. (2) Bovine ketosis.(3) Musculoskeletal conditions.(4) Shock.(5) Parturient paresis (supportive stress therapy for milk fever).
03.10.09
Saxagliptin (as HCl) 2.5mg/ 5mg Tablets
As an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus. (It should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.
24.10.09
Calcipotriol Gel 0.005% (additional dosage form)
For the treatment of moderate plaque psoriasis in adults
3.10.2009
Lamotrigine MR Tablets 150mg (Addl. Strength)
same as approved
3.10.2009
Metoprolol Tartrate ER Tablet 75mg (additional strength)
same as approved
3.10.2009
Valganciclovir Powder for Oral Solution 50mg/ml
For the treatment of cytomegalovirus (CMV) retinitis in AIDS patients and for prevention of CMV disease in solid organ transplant patients at high risk
9.10.2009
Dexketoprofen Trometamol Gel 12.5mg/gm
For the painful and inflammatory conditions associated with joints, tendons, ligaments and muscle
13.10.2009
Donepezil Hydrochloride Orodispersible Tablet 5mg/10mg
For the treatment of mild to moderate severe Alzheimer's Dementia
15.10.2009
Dexketoprofen Trometamol Injection 50mg/2ml
Symptomatic treatment of acute pain of moderate to severe intensity, when oral administration is not appropriate such as post-operative pain, renal colic and low back pain.
22.10.2009
Bromocriptine Mesylate Tablet IP 0.8mg, (additional Indication)
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
22.10.2009
Levosulpride ER Tablet 100/150/200mg
For the treatment of depression and schizophrenia in adults
27.10.2009
Ambroxol 30 mg+ Terbutaline 2.5 mg + Guaiphenesin 100mg + Menthol 2.5 mg per 5 ml syrup
Additional strength
27.10.2009
Propofol 10 mg+ Lignocaine 2.5 mg per ml injection
Additional strength
27.10.2009
Mecobalamin 750 mg + Pyridoxine Hydrochloride1.5 mg + Nicotinamide 45 mg tablets
For the treatment of diabetic neuropathy
27.10.2009
Olmesartan (20/40mg )+ Atorvastatin 5/10/20mg film coated tablets
For the treatment of co-existing essential hypertension and hyperlipidemia in adult patients
27.10.2009
Reference: http://cdsco.nic.in/listofdrugapprovedmain.html
Friday, January 22, 2010
Executive Interview : Q&A with Dr.B.Suresh on Pharm.D. program in India
In a tete a tete with Dr. B.Suresh, President of Pharmacy Council Of India & the esteemed President of The Indian Pharmaceutical Association , the students of the publication team of IPA-SF addressed him to speak up a few words about the latest Pharm.D. Program launched in India.
Catch up with what he has to say on the upcoming boon in the field of Pharmacy- Pharm.D.
1. You are one of the main driving force behind the introduction of PharmD course in India. Could you please explain the thought processes behind introducing this course and major challenges that you came across in introducing this course?
As The President of PCI , the idea of commencing the Pharm.D. program is the brainchild of professionals from The Pharmacy Council of India headed by me & stalwarts from the field of pharmacy, who feel that after 50 years of being a part of the health care industry the pharmacists should gain a global experience in the field of Hospital & Community Pharmacy.
This experience will enable the pharmacist to advise, consult & help doctors in dispensing medicines to patients, to play a role that is based on KNOWLEDGE and NOT JUST POSITION of the individual and also provide the pharmacist with a role at par with doctors.
In order to achieve these objectives, the curriculum has been redesigned for students who wish to pursue an experimental career in clinical trials.
Students who wish to migrate globally are often faced with problems regarding eligibility for the course & about recognition of the Indian degree in foreign states.
Hence we have come up with a program of {B.Pharm + Pharm.D(3 years)} which gives a global edge to students
2. What is the basic difference between PharmD and PG (post baccalaureate) course?
PG is specialization in a particular field such as Pharmaceutics, Quality Assurance and Pharmaceutical Chemistry. In Pharm.D there is no specific area of specialization. It is based on a clinical aspect (related to trials and experiments)
3. What would be job prospects for Pharm.D graduates in India? What kind of jobs should they expect?
A Pharm.D graduate could find jobs mostly related to the clinical force of India. With gradual amendments being made in the health care industry, the Pharm.D graduate could play an active role in heading the Hospital Pharmacy Setting (Hospital Setting/ Hospital Pharmacy)
Also with a large number of Pharmaceutical companies opting for clinical trials the industry is heading towards a business worth 1.4 billion by way of clinical trials.
As the Ayurvedic doctors conduct clinical trials so also the Pharm.D program concentrates on giving these graduates an opportunity to conduct clinical trials and clinical studies. Meanwhile, a Pharm D. graduate could work at industries that deal with clinical trials related to product line & product pipeline.
4. As you know, the current pharmacy graduates (B-Pharm/M-pharm) who passed out after 2003 are not eligible to write FPGEE in USA. Are these PharmD graduates eligible to writeFPGEE in USA?
It could not be said right now as it is usually on the basis of a case by case evaluation. There are NABP and other agencies which are dealing with aspects of foreign education. However, we do not believe in producing pharmacists for the overseas market but in updating the quality of our pharmacists here. We are trying to create an educational board such that it receives international approval.
5. Right now, role of pharmacists in pharmaceutical care is almost zero in India... Is there any foundation being laid down to make pharmacists a part of the health care systems in India? What efforts are going on towards that?
Earlier since there were not many health care services the pharmacists did not play a significant role. Pharmacists have mostly been involved in the industrial aspect of health care. But now with the introduction of Pharm.D we expect more clinical trials taking place & a forthcoming change that will strengthen the role of the Pharmacist in the Health Care system very soon.
Cortasy ... http://www.pharmainfo.net/interviews/executive-interview-qa-drbsuresh-pharmd-program-india
Thursday, January 14, 2010
FDA weighs e-inserts or paperless labeling
The FDA is weighing whether to allow a system for electronic insert information for most prescription drugs, replacing paper Rx inserts.
Is it time to make prescribing information electronic and forgo paper package inserts for most prescription drugs? Manufacturers have long led an effort to move toward "paperless labeling," which they say could save millions of dollars. Now the Food & Drug Administration is exploring the idea with a call for comments and a recent hearing at its Rockville, Md., offices.
View Full Article
Journal:
Drug Topics, Jun 4, 2007
Copyright:
© Advanstar Communications. All rights reserved.
FDA's Approvable Problem
They scuttle product launches and send company stocks through the floor. They steal precious years from patents and require pricey new trials. They have the entire drug industry on edge, from struggling one-hit biotechs to struggling large-cap pharmas. They're FDA approvable letters—that odd regulatory response that isn't quite an approval and isn't quite a rejection—and in the past three or four years, they've become a major part of the FDA's arsenal for dealing with (or, as many say, not dealing with) new drug applications (NDAs).
As of October 1, the agency had already issued 23 approvable letters this year, including second letters for four drugs and a third for one. After hearing industry insiders grumble that a scared-safe FDA was upping the letter's use, Chris Milne of the Tufts Center for Drug Development looked into the issue in 2005 and counted 35 approvable letters for NDAs between 2001 and 2004, causing an average delay until approval of 20 months. FDA has issued 36 such letters since January 2006 alone.
View Full Article
Journal:
Pharmaceutical Executive, Nov 1, 2007
Copyright:
© Advanstar Communications, Inc. All rights reserved.
Tuesday, January 12, 2010
S.T.D
Sexually transmitted diseases are a general term that refers to as many as twenty different illnesses. These are transmitted by sex - usually through the exchange of bodily fluids such as semen, vaginal fluid, and blood. STD's such as herpes, can be acquired by kissing or close contact with infected areas - not just intercourse. If left untreated, STD's can cause permanent damage that leaves you blind, brain-damaged, or sterile. HIV (human immunodeficiency virus) disease, often leads to AIDS (acquired immune deficiency syndrome), which can cause death.
The most common STD's are chlamydia, herpes, gonorrhea, genital warts, syphilis, hepatitis B, crabs, and trichomoniasis.
STD's can be prevented, most can be cured. They infect men, women, and children. Mothers can also give STD's to their babies. Anyone at any age can be a victim. It is not true that having had an STD once and having been cured, you will not get it again. This section will describe STD's and some simple steps for protection of both partners.
Who Gets STD's:
Anyone who has sex can get a sexually transmitted disease and millions do. More than 4 million people get chlamydia each year. Genital herpes affects an estimated 30 million Americans, with as many as 500,000 new cases reported each year. There are over 1 million cases of gonorrhea each year. And syphilis, once thought to be on the decline, has made a rising comeback in the last four years.
Chlamydia: - is one of the most common STD's in the United States today. Almost 5 million people are infected with this disease each year. Chlamydia is a germ that commonly infects the cervix and may spread to the uterus and the fallopian tubes.
How You Get It:
The disease is passed on through sex, including oral sex with an infected person. It is easier to get chlamydia if a condom is not used. Chlamydia often occurs with other STD's, especially gonorrhea.
How It Is Transmitted:
Chlamydia is transmitted by passing germs (bacteria) from one person to another when having sex.
What It Looks Like - What The Symptoms Are:
Chlamydia frequently doesn't cause any signs that are visible. Sometimes it does. Visible signs appear in 1 to 3 weeks after having sex with an infected person. Men may see a yellow discharge from the penis or a slight crusting at the tip of the penis. They can also experience severe burning during urination. Women may see a yellowish discharge from the vagina or feel pain in the stomach. Women can also experience severe burning during urination.
How You Get Tested For It:
A healthcare provider will collect a sample from the penis or vagina to be sent out for culture. This will take a few days. They will also use clinical indicators to determine if chlamydia exists. This will require an exam of the cervix or penis and indication of discharge.
Treatments:
Chlamydia is treatable and can be cured. Antibiotics will be given to kill the bacteria.
If Left Untreated:
Would result in serious infections. Women would be extremely vulnerable to pelvic inflammatory disease (PID) and possible sterility.
Prevention:
Use a condom and spermicide (nonoxynol-9).
CRABS: -cause itching which leads to scratching and inflammation. They attach themselves to pubic hairs with their claws and suck blood from the host into their digestive system. They also lay eggs on the hair shaft.
How You Get Them:
Crabs are transmitted by having sex with an infected partner. They are also spread by sharing clothes, sheets, or towels with an infected person.
How They Are Transmitted:
Crab lice jump from one person to another, usually during sex.
What They Look Like - What The Symptoms Are:
Crabs are one of three lice that infect the human body. They are very small insects that crawl around in the pubic areas. They can also be found in facial and body hair. Due to the severe itching they cause, they are often felt before they are seen. This itching can take up to 5 days before it is noticed. Sometimes the crabs and their nits (eggs) can be seen on the hair shafts.
How You Get Tested For Them:
A healthcare provider will examine the area where the itching is occurring. A closer study of the pubic hairs can show the presence of nits (eggs).
Treatments:
Crabs are very treatable. A healthcare provider will recommend a lotion or powder, normally a pediculocide, to eliminate them. Most of these products are available as non-prescription items. Remember, anyone is contagious until all crabs and their nits are eliminated.
If Left Untreated:
Left untreated, crabs will not go away. The itching will continue and as will the contagious condition to any partners. Excessive scratching may lead to a superinfection.
Prevention: Questioning or examination of a partner.
Cytomegalovirus (CMV)
How You Get It:
Cytomegalovirus (CMV) is contracted by having sex with an infected partner. It is easier to get CMV if a condom is not being used. Children can get CMV through the air. The virus also lives in urine.
How It Is Transmitted:
The CMV virus is transmitted during sex from one person to another.
What It Looks Like - What The Symptoms Are:
CMV does not always cause symptoms that are noticeable. Fever, muscle ached, or a tired feeling may be noticed. In rare cases CMV can cause a lack of mobility in the arms or legs, swelling of the brain or heart, and a thinning of the blood (anemia). People with an impaired immune system may feel very fatigued, or have trouble breathing or seeing.
How To Get Tested For It:
A small amount of fluid or skin from the penis or vagina will be collected by a qualified medical professional and sent to a laboratory for examination. Another option is to take a blood sample and send it to the laboratory. Either method will take 2-3 days to get the results.
Treatments:
For people with normal immune systems, there are no current treatments available. For those with impaired immune systems, there are two possible treatments for retina infections. One of these two products has also shown some benefit in the treatment of CMV infections of the gastrointestinal tract and to a lesser degree, the lung.
What Will Happen To Those With CMV:
As with many viral infections, once infected with CMV, always infected. It also has periods of little to no viral activity and other periods of great viral activity. This is usually represented by symptoms that come and go in a normal, healthy person. For those with impaired immune systems, severs blood diseases, lung problems or even blindness can result from the infection. Unlike herpes, CMV can be passed on even in a stage of low viral activity.
Prevention:
A latex condom, preferably used with a spermicide, is the best protection against the spread of viral diseases.
GENITAL HERPES (HSV): -, usually HSV-2, is an infection caused by a virus. It belongs to a family of herpes viruses that cause chickenpox, cold sores, shingles, and mononucleosis. Once infected, herpes remains in the body for the life span of the host. HSV-2 is the cause of genital lesions in about 80-85% of all cases. The balance is caused by a related strain of HSV-1. This strain is usually found around the mouth (cold sores) and nose. Most cases of HSV-1 in the genital area come from oral-genital contact. Fortunately, both strains respond well to current treatments.
How You Get It:
Herpes is acquired by having sex or personal contact (kissing, touching, etc.) with an infected person. An infected person is contagious from the moment of prodrome (burning, pain, itching) until the sores are completely healed.
How It Is Transmitted:
Infection occurs when the virus passes through a break in the skin or penetrates the moist mucosal membranes of the penis, vagina, cervix, or anus.
What It Looks Like - What The Symptoms Are:
About 2-10 days after having sex with an infected partner, flu-like symptoms such as swollen glands, fever, muscle aches, fatigue, and nausea may appear. Early symptoms (prodrome) include a burning sensation when urinating; pain in the buttocks, legs or genital area; a feeling of pressure in the genital area; or a discharge from the vagina. Sores appear as a small, fluid-filled blisters on the genitals, buttocks, or other infected areas. Later these blisters will dry-out, crust over, and heal.
The first bout can last up to three weeks. About 90% of those infected will have recurrence at some time. The rate of recurrence varies greatly for each infected
person. Recurrences in a normal host normally last about a week.
How To Get Tested For It:
A qualified medical professional will collect a small sample of fluid from one of the lesions and send it to a laboratory for a viral culture. The results can take up to two weeks. It is very difficult to test for HSV if there are no lesions present and is most effective early in the outbreak.
Treatments:
Herpes cannot be cured but it can be treated. Antiviral capsules or ointment can shorten the length of the outbreak and make the sores less painful. If you have frequent repeat outbreaks, your healthcare provider can work out a specific daily regimen to reduce or eliminate them completely. Keep all lesions clean and dry, and avoid tight fitting clothes.
If Left Untreated:
Once infected, the symptoms may go away, but they can come back. If left untreated, recurrences will last longer and have more discomfort. As with any virus, even when less active it is possible to transmit the virus to a partner.
Prevention:
Abstain from sex during infectious periods (outbreaks). Wear protection in the form of latex condoms. If there are any lesions or scabs present, avoid any contact.
Genital warts: - are caused by the human papilomavirus (HPV). There are many types of HPV. Those that cause condyloma are different from those that cause common warts on the hands or feet.
How You Get It:
Genital warts are passed on during sexual intercourse - genital, oral, or anal, with an infected person. It is easier to get condyloma if a condom is not used.
How It Is Transmitted:
Genital warts are transmitted when the virus is passed from one partner to another during sex.
What They Look Like - What The Symptoms Are:
Genital warts do not always cause signs that are visible. When it does, they are noticeable 3 days to 3 weeks after infection. It takes years for signs to show up in some people. Warts can appear in clusters or as one or two small bumps. In women, warts can be present in the vulva, perineum, cervix, vagina, or anus. In men, warts usually appear on the penis and are sometimes found on the scrotum.
How To Get Tested For It:
A qualified medical professional will look at the genital area. They can also check areas that are not easily visible, especially in the woman. For example, they can retrieve a sample of cells from the cervix to examine for the virus or use a colposcope, a magnifying instrument, to look directly in the vagina and cervix.
Treatments:
There are many different treatments available today. Most have a success rate of better than 80%. Warts can now be removed through a variety of surgical procedures like laser, cold steel, and hot cautery. There are also a number of applied treatments like caustic agents TCA and BCA, podophyllin resin, and podofilox solution. Some warts do return and may require further treatment. Always have the partner examined by a healthcare professional to prevent reinfection.
If Left Untreated:
The HPV virus remains in the body and can cause warts at any time. Left untreated, these warts can become large and difficult to treat. Certain types of warts have been linked changes in tissues that could lead to cancer. During pregnancy, genital warts can grow very quickly and can even interfere with a normal vaginal delivery. As with any virus, the risk of passing condyloma on to a partner is always present.
Prevention:
Avoid sexual contact until all warts are gone. Wearing protection in the form of a latex condom or abstinence.
Gonorrhea:- is a very common STD. It is caused by a germ that grows quickly in the warm, moist areas of the body. The most common place it is found is in the cervix. It can also occur in the mouth, throat, rectum, and urinary tract.
How To Get It:
The disease is passed on through sex with an infected person. It is easier to get gonorrhea if a condom is not used.
How It Is Transmitted:
Gonorrhea is transmitted by passing germs (bacteria) from one person to another when having sex.
What It Looks Like - What The Symptoms Are:
Visible signs of gonorrhea usually appear within 2 to 10 days after infection. Men may see a yellowish discharge from the penis and a burning sensation when urinating. Women may see a yellowish discharge from the vagina and have a burning sensation when urinating. Later difficulties are bleeding between periods, swollen joints, fever, or pain in the pelvic area.
How You Get Tested For It:
A health care provider will collect a fluid sample from the penis or vagina to be sent to a laboratory for a culture. This will take a few days for the results.
Treatments:
Gonorrhea is treatable and can be cured. Antibiotics, in the form of an injection or pills, will be given to kill the bacteria. Follow the dosing instructions thoroughly.
If Left Untreated:
Would result in serious infections. Women would be extremely vulnerable to pelvic inflammatory disease (PID) and possible sterility.
Prevention:
Use a condom and spermicide (nonoxynol-9)
Hepatitis B virus (HBV): - is a widely distributed pathogen that is able to produce both acute and chronic infections.
How You Get It:
The disease is passed by having sex with an infected person. It can also be contracted through contaminated blood. Practices such as sharing needles during drug use increase the risk of contracting HBV. It is easier to get hepatitis if a condom is not used.
How It Is Transmitted:
Hepatitis B is transmitted during sex with an infected partner or when sharing needles during drug use.
What It Looks Like - What The Symptoms Are:
All signs of hepatitis B are related to liver dysfunction, which is what the virus causes. The signs include loss of appetite, weakness, nausea, vomiting, pain in the stomach, and a yellowing of the skin or the white part of the eye. Some of these signs are also signs of other diseases. Therefore, having any of these should be sufficient reason to see a qualified medical professional.
How To Get Tested For It:
A healthcare professional will take a blood sample and send it to a laboratory. The results can take up to two weeks to return.
Treatments:
Hepatitis B can be treated, but there is no current cure for it. An intramuscular injection is given to control damage to the liver and control the disease.
If Left Untreated:
Serious liver damage.
Prevention:
Avoid or eliminate high-risk behavior (shared needles during drug use). Consider vaccination.
Human immunodeficiency virus, or HIV disease: -, is a spectrum of illnesses caused by the human immunodeficiency virus (HIV). The disease was first recognized in the very early 1980's. HIV disease represents a potential threat to everyone - men, women, and children. The number of deaths, people with symptoms, and people infected, continues to climb at an alarming rate. From the beginning of the epidemic people of all sexes, ages, and backgrounds have been affected.
Very simply, HIV destroys the body's immune system over a period of time by killing the white cells that to respond to and destroy other infections. As people with HIV progress in their disease, they have less and less ability to fend off these infections or cancers. Most people who die from this disease succumb to one of these other infections.
How You Get It:
The disease is passed on through unprotected sex with an infected partner. Any potential blood contact with an infected person (shared drug needles, anal sex) increases the risk potential dramatically.
How It Is Transmitted:
Infection occurs when the virus is passed from an infected partner during sex or when needles are shared during drug use. The virus passes through a break in the skin or penetrates the moist mucosal membranes of the penis, vagina, cervix, anus, or oral cavities.
What It Looks Like - What Are The Symptoms:
HIV is unique because it often presents with no symptoms for an extended period of time after infection. A person could be infected with HIV, not feel sick, and not be aware of the danger they present to themselves and others. This period of asymptomatic (no symptoms) infection can last years.
When HIV symptoms do present, they come in many forms. Some are related to HIV infection while others are due to infections attacking the body in its weakened state. Therefore, any combination of symptoms may appear and should be reason to seek qualified medical attention immediately. Some of the symptoms are: Lumps in the armpits, neck or groin; purple spots on the skin; purplish raised bumps on the skin; skin rashes, boils, or sores; growths beneath the skin; growths on the skin that line the mouth, nasal passages, anus, vagina, or inside the eyelids; a heavy white coating of the tongue (thrush); shingles; unexplained weight loss; fever or night sweats; ongoing dry cough or shortness of breath; persistent diarrhea; bleeding without cause from any body opening; being tired, dizzy, or faint frequently; difficulty swallowing; difficulty with urination or bowel movements; persistent pain; memory loss, blurred vision, and changes in hearing, smell, or taste.
In the later stages of disease, patients suffer a range of rare and unique infections. These include PCP (a form of pneumonia), Kaposi's sarcoma (a form of skin cancer), and cytomegalovirus (CMV). These infections are very debilitating, can recur, and often cause death.
How You Get Tested For It:
A qualified medical professional will take a blood sample and send it to a laboratory for one of two tests, the Western Blot test or the ELISA test. These tests are often done sequentially to verify the previous readings. In most cases the results are returned in about three days but it can take up to two weeks. The test can be done in a physician's office, a local clinic, or a specific testing center. These can be found in the local phone book.
There are two ways to be tested, anonymously or confidentially. Anonymous testing does not require a name. The patient is given a number for follow-up and test results. Confidential testing requires a name, but results and information is not to be given out without the patients consent. Some states, not all, offer both types of testing. Check with a local hotline or medical society to find out what is available in your area.
Treatments:
There are a number of antiviral drugs available to slow the progression (increase of virus in the body) of the disease. These can be used alone or in combination. A healthcare provider can optimize a plan to meet each person’s specific needs. There are also a growing number of therapies available to combat the other infections that attack the body.
If Left Untreated:
The disease can progress faster and the patient is more likely to experience other infections sooner.
Prevention:
To find out more about the HIV disease, contact a qualified medical professional; a local AIDS Support Organization (ASO); or other qualified person. If in doubt about a partner, assume that protection is required. Condoms have demonstrated an ability to reduce the transmission of the HIV virus when used properly.
Syphilis:- is a chronic infectious disease.
How You Get It:
The disease is transmitted by having sex with an infected partner. It is easier to get syphilis if a condom is not used.
How It Is Transmitted:
Syphilis is transmitted by passing germs (bacteria) from one person to another when having sex. Other potential routes of transmission include contaminated blood (shared needles) and mother to baby transmission.
What It Looks Like - What The Symptoms Are:
Patients with untreated syphilis are classified in a series of stages. The primary stage begins immediately after exposure. The first symptom usually occurs 1 to 12 weeks after infection and is defined by the presence of a chancre. The sore usually develops at the site of initial lesion contact. This could be on the external genitals but may develop inside the vagina, rectum, mouth, or throat and may go unnoticed. The sore will go away on its own but the disease process continues.
Secondary syphilis usually occurs 4 to 10 weeks after the chancre appears. At this time a number of obvious clinical signs become apparent. A skin rash develops and may cover a few areas or the entire body. Flu-like symptoms also frequently occur at or about the same time. Again, these symptoms will disappear but the disease remains. Many people now move to a latent period where no symptoms are apparent. This is followed by tertiary syphilis, which can end in death.
How You Get Tested For It:
A healthcare provider will take a sample of skin or fluid from the genital area to determine if there is early stage (primary or secondary) disease. To test for disease further along, a blood test will be required. It usually takes a few days for the results to return.
Treatments:
Syphilis is treatable and curable, most easily in the early stages by penicillin shots.
If Left Untreated:
Untreated syphilis can lead to blindness, heart disease, brain damage, and death.
Prevention:
The regular use of condoms reduces the transmission of syphilis.rs, see section on Safe Sex.
Trichomoniasis .
How You Get It:
Trichomoniasis is passed on through sex with an infected partner. It is easier to get trichomoniasis if a condom is not used.
How It Is Transmitted:
Trichomoniasis is transmitted by passing germs (protozoa) from one person to another when having sex.
Itching in and around the vagina along with a deep red-colored rash are signs of trichomoniasis. Women also may see a gray discharge, a frothy-yellowish discharge, or a slightly bloody discharge from the vagina. Women can range from no symptoms to a severe inflammatory disease. For women, symptoms of acute trichomoniasis often occur during or immediately menstruation. Men may show a similar discharge in about half of the cases but often have no symptoms. The incubation period has been estimated between 3 to 28 days after initial infection.
How You Get Tested For It:
A healthcare provider will collect fluids from the genital area for women and take a urine test from men. These are sent to a laboratory for examination. It usually takes a few days to get the results back.
Treatments:
Trichomoniasis is treatable and curable. A seven-day regimen of pills provides a 95% cure rate.
Prevention:
The regular use of a condom reduces the transmission of trichomoniasis.
CONCLUSION
Only a qualified medical professional can identify and treat a sexually transmitted disease. The information provided in this section only serves as a general guideline. Your healthcare professional must decide whether a symptom indicates the presence of an STD, and which one. Do not attempt to make this decision alone. Waiting to seek guidance and treatment can also be detrimental. Since many STD's are treatable, the sooner they are identified, the easier it is to effectively treat the disease with the least amount of damage to your body. Also remember that there is always a partner that will require treatment. Without it, reinfections and new infections will continue to rise.
Saturday, January 9, 2010
VISUAL PROBLEMS
There are many types of eye problems and visual disturbances. These include blurred vision, halos, blind spots, floaters, and other symptoms. Blurred vision is the loss of sharpness of vision and the inability to see small details. Blind spots (scotomas) are dark "holes" in the visual field in which nothing can be seen. For the most severe form of visual loss.
Considerations
Changes in vision, blurriness, blind spots, halos around lights, or dimness of vision should always be evaluated by a medical professional. Such changes may represent an eye disease, aging, eye injury, or a condition like diabetes that affects many organs in your body.
Whatever the cause, vision changes should never be ignored. They can get worse and significantly impact the quality of your life. Professional help is always necessary. As you determine which professional to see, the following descriptions may help:
- Opticians dispense glasses and do not diagnose eye problems.
- Optometrists perform eye exams and may diagnose eye problems. They prescribe glasses and contact lenses. In some states, they treat diseases that affect the eyes.
- Ophthalmologists are physicians who diagnose and treat diseases that affect the eyes. These doctors may also provide routine vision care services, such as prescribing glasses and contact lenses.
- Sometimes an eye problem is part of a general health problem. In these situations, your primary care provider should also be involved.
Causes
Vision changes and problems can be caused by many different conditions:
- Presbyopia -- difficulty focusing on objects that are close. Often becomes noticeable in your early to mid 40s.
- Cataracts -- cloudiness over the eye's lens, causing poor nighttime vision, halos around lights, and sensitivity to glare. Daytime vision is eventually affected. Common in the elderly.
- Glaucoma -- increased pressure in the eye, causing poor night vision, blind spots, and loss of vision to either side. A major cause of blindness. Glaucoma can happen gradually or suddenly -- if sudden, it's a medical emergency.
- Diabetic retinopathy -- this complication of diabetes can lead to bleeding into the retina. Another common cause of blindness.
- Macular degeneration -- loss of central vision, blurred vision (especially while reading), distorted vision (like seeing wavy lines), and colors appearing faded. The most common cause of blindness in people over age 60.
- Eye infection, inflammation, or injury.
- Floaters -- tiny particles drifting across the eye. Although often brief and harmless, they may be a sign of retinal detachment.
- Retinal detachment -- symptoms include floaters, flashes of light across your visual field, or a sensation of a shade or curtain hanging on one side of your visual field.
- Optic neuritis -- inflammation of the optic nerve from infection or multiple sclerosis. You may have pain when you move your eye or touch it through the eyelid.
- Stroke or TIA.
- Brain tumor.
- Bleeding into the eye.
- Temporal arteritis -- inflammation of an artery in the brain that supplies blood to the optic nerve.
- Migraine headaches -- spots of light, halos, or zigzag patterns are common symptoms prior to the start of the headache. An ophthalmic migraine is when you have only visual symptoms without a headache.
Other potential causes of vision problems include fatigue, overexposure to the outdoors (temporary and reversible blurring of vision), and many medications.
Medications that can affect vision include antihistamines, anticholinergics, digitalis derivatives (temporary), some high blood pressure pills (guanethidine, reserpine, and thiazide diuretics), indomethacin, phenothiazines (like Compazine for nausea, Thorazine and Stelazine for schizophrenia), medications for malaria, ethambutol (for tuberculosis), and many others.
Home Care
Safety measures may be necessary if you have any vision problems. For example, if you have trouble seeing at night, you should not drive after dusk. It may be helpful to increase the amount of light in a room or arrange a home to remove hazards. A specialist at a low-vision clinic may be able to help.
Subscribe to:
Posts (Atom)